复发性侵袭性脑膜炎球菌感染:德国2002至2018年风险量化
德国国家参考实验室分析2002至2018年5854例侵袭性脑膜炎球菌病患者,中位观察9.4年,14例发生第二次感染、1例第三次感染,幸存者复发风险为每10万人年29.4例,较一般人群至少高50倍,罕见血清群在复发患者中更常见,支持对幸存者接种疫苗。
要点
- 侵袭性脑膜炎球菌病幸存者复发风险为29.4/10万人年,较一般人群至少高50倍。
- 复发患者中罕见血清群(Y、W、E、Z)更常见(p < 0.0001)。
- 复发风险可能被低估,或与未诊断的补体缺陷有关,支持对幸存者接种疫苗。
核心结论
- 侵袭性脑膜炎球菌病幸存者发生再次感染的风险较一般人群至少高50倍,支持对幸存者进行疫苗接种。
研究设计与样本
- 德国国家脑膜炎球菌和流感嗜血杆菌参考实验室对2002至2018年侵袭性脑膜炎球菌病病例进行回顾性分析,共纳入5854例患者,中位观察期9.4年。
主要发现
- 5854例患者中14例发生第二次侵袭性脑膜炎球菌病,1例发生第三次。
- 幸存者复发风险为每10万人年29.4例。
- 复发患者中罕见血清群(Y、W、E、Z)更常见(p < 0.0001)。
关键数值与推荐
- 复发定义为首次侵袭性脑膜炎球菌病发作30天以后,在同一患者样本中再次检出脑膜炎奈瑟菌。
临床怎么用
- 对侵袭性脑膜炎球菌病幸存者应评估并考虑接种疫苗以预防再次感染。
- 临床应警惕幸存者复发风险,必要时筛查补体缺陷。
局限性
- 研究很可能低估了复发感染的风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IntroductionInvasive meningococcal disease (IMD) is a rare condition with a high case fatality rate. While most patients suffer from one single episode in life, there is anecdotal evidence for recurrent infection.AimThe German National Reference Laboratory for Meningococci and Haemophilus influenzae (NRZMHi) analysed IMD cases from 2002 to 2018 to retrospectively quantify the risk of recurrent infection.MethodsRecurrent IMD was defined as detection of Neisseria meningitidis in a sample of the same patient more than 30 days after the first episode of IMD.ResultsAmong 5,854 patients with a median observation period of 9.4 years, 14 suffered a second IMD episode and one patient a third one. The risk of a recurrent IMD was 29.4 per 100,000 person-years for survivors of the first episode. Rare serogroups (Y, W, E and Z) were more common in patients with recurrent IMD (p < 0.0001).DiscussionPatients surviving IMD were at least at a 50-fold risk of another IMD episode compared with the general population. The study most likely underestimated the risk of recurrent infection. Increased risk may be due to undiagnosed complement deficiencies. The high risk of re-infection argues for vaccination of patients who have survived IMD.
引用
- Krone M, Lâm TT, Claus H, et al. Recurrent invasive meningococcal infections - quantifying the risk, Germany, 2002 to 2018. Euro Surveill. 2020. PMID: 32613936. doi:10.2807/1560-7917.ES.2020.25.25.1900565
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。